ArticleInternational journal of clinical oncology2026
Erlotinib plus bevacizumab in EGFR-amplified metastatic solid tumors: results from the KOSMOS I, II study of molecular profiling-guided therapy in advanced cancers.
Jiwon Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.